PharmaDrug Inc. announced that Mr. Robert Schwartz has resigned from the board of directors of the Company (the "Board"), and the Board has accepted his resignation. Effective immediately, the Company will appoint current Board member David Kideckel to replace Mr. Schwartz on the Company's Audit Committee. Mr. Kideckel recently joined the Board on August 30th, 2021 and has over 20 years of combined industry and capital markets experience, most recently serving as Managing Director, Senior Institutional Equity Research Analyst at ATB Capital Markets.

The Company will not be appointing any new Board members at this time as no Board members were removed in connection with Mr. Kideckel's appointment.